Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Breast Neoplasms 7 Surgical Wound Infection 5 Pilonidal Sinus 3 Wound Infection 2 Sarcoma 2 Thyroid Nodule 1 Thyroid Neoplasms 1 Thyroid Diseases 1 Spinal Cord Injuries 1 Skin Neoplasms 1 Skin Carcinoma 1 Seroma 1 Postoperative Complications 1 Obesity 1 Non-melanoma Skin Cancer 1 Neoplasm Metastasis 1 Infections 1 Graves Disease 1 Goiter 1 Esophageal Neoplasms 1 Anastomotic Leak 1 Adenocarcinoma 1

Interventions

Oxaliplatin 46 Gemcitabine 45 Fluorouracil 40 Capecitabine 31 pembrolizumab 30 Leucovorin 29 Docetaxel 27 Cisplatin 25 Paclitaxel 23 Irinotecan 18 Carboplatin 18 Bevacizumab 18 130-nm albumin-bound paclitaxel 17 Radiotherapy 16 Pemetrexed 15 Albumin-Bound Paclitaxel 15 Nivolumab 13 Ramucirumab 11 Cyclophosphamide 11 Drug Therapy 9 Trastuzumab 8 Erlotinib Hydrochloride 8 zolbetuximab 7 Taxes 7 Radiosurgery 7 trastuzumab deruxtecan 6 cemiplimab 6 Blood Specimen Collection 6 regorafenib 5 durvalumab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Adenocarcinoma × Negative-Pressure Wound Therapy × Clear all

NCT07489820 2026-05-22

AAPICO

Centre Hospitalier Departemental Vendee

Phase NA Not yet recruiting

Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡